{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreic33vqkvu5i32nqlqalc6iiuxomx43oiukjgsvh333n44xbzv6nlm",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mehjrhrm4ta2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidhql4suh7ruipsso4wuxedacafwgan6hydp6hxhmzkm2gxbqvbnu"
    },
    "mimeType": "image/jpeg",
    "size": 134781
  },
  "path": "/2026/02/09/fda-rejects-regenxbio-rare-disease-gene-therapy/?utm_campaign=rss",
  "publishedAt": "2026-02-09T21:24:37.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "Gene therapy",
    "rare diseases",
    "STAT+"
  ],
  "textContent": "The Food and Drug Administration has rejected a rare-disease gene therapy from Regenxbio, the company said Monday.",
  "title": "STAT+: FDA rejects Regenxbio’s rare-disease gene therapy",
  "updatedAt": "2026-02-09T21:24:43.000Z"
}